论文部分内容阅读
1984年以来,我院对86例麻风进行联合化疗,现将有关临床、细菌、麻风反应和毒副作用的观察,以及停药监测结果报告如下。 1. 对象与方法 1.1 病例选择:共有患者89例,接受联合化疗(MDT)的86例,占96.6％。其中瘤型(LL)44例,界线类偏瘤型(BL)14例,中间界线类(BB)6例,界线类偏结核样型(BT)22例。男58例,女28例。年龄15～85岁,平均47.4岁。病期0.5～42年,平均6.7年。分为初治组(未经抗麻风治疗)50例,经治组(曾用过抗麻风药物)36例。86例麻风中属复发病例的36例。
Since 1984, our hospital on 86 cases of leprosy combined with chemotherapy, now the clinical, bacterial, leprosy reactions and toxic side effects of the observation, and the withdrawal monitoring results are reported as follows. 1. Subjects and methods 1.1 Case Selection: A total of 89 patients, 86 cases received combined chemotherapy (MDT), accounting for 96.6%. Among them, 44 were tumor type (LL), 14 were marginal line type (BL), 6 were middle line type (BB) and 22 were borderline type (BT). 58 males and 28 females. Aged 15 to 85 years old, with an average of 47.4 years old. Disease period 0.5 to 42 years, an average of 6.7 years. Divided into primary treatment group (without anti-leprosy treatment) 50 cases, the rule group (used anti-leprosy drugs) in 36 cases. Among 86 cases of leprosy, 36 cases were relapsed.